nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—CYP2C19—Thalidomide—leprosy	0.236	0.282	CbGbCtD
Metoprolol—CYP2C19—Rifampicin—leprosy	0.228	0.273	CbGbCtD
Metoprolol—CYP2C19—Dapsone—leprosy	0.189	0.225	CbGbCtD
Metoprolol—ABCB1—Rifampicin—leprosy	0.184	0.22	CbGbCtD
Metoprolol—Rales—Thalidomide—leprosy	0.00601	0.0369	CcSEcCtD
Metoprolol—Altered state of consciousness—Thalidomide—leprosy	0.00534	0.0328	CcSEcCtD
Metoprolol—Sexual dysfunction—Thalidomide—leprosy	0.0044	0.027	CcSEcCtD
Metoprolol—Psoriasis—Thalidomide—leprosy	0.00392	0.0241	CcSEcCtD
Metoprolol—Cyanosis—Thalidomide—leprosy	0.00348	0.0214	CcSEcCtD
Metoprolol—Photosensitivity reaction—Dapsone—leprosy	0.00276	0.0169	CcSEcCtD
Metoprolol—Hearing impaired—Thalidomide—leprosy	0.00259	0.0159	CcSEcCtD
Metoprolol—Atrioventricular block—Thalidomide—leprosy	0.00254	0.0156	CcSEcCtD
Metoprolol—Depressed level of consciousness—Thalidomide—leprosy	0.00238	0.0146	CcSEcCtD
Metoprolol—Dry eye—Thalidomide—leprosy	0.00228	0.014	CcSEcCtD
Metoprolol—Tinnitus—Dapsone—leprosy	0.00226	0.0138	CcSEcCtD
Metoprolol—Lightheadedness—Thalidomide—leprosy	0.00221	0.0135	CcSEcCtD
Metoprolol—Mental disability—Thalidomide—leprosy	0.00214	0.0131	CcSEcCtD
Metoprolol—Diabetes mellitus—Thalidomide—leprosy	0.00206	0.0126	CcSEcCtD
Metoprolol—Photosensitivity—Thalidomide—leprosy	0.00204	0.0125	CcSEcCtD
Metoprolol—Deafness—Thalidomide—leprosy	0.002	0.0123	CcSEcCtD
Metoprolol—Vision blurred—Dapsone—leprosy	0.00198	0.0122	CcSEcCtD
Metoprolol—Cardiac failure congestive—Thalidomide—leprosy	0.00197	0.0121	CcSEcCtD
Metoprolol—Libido decreased—Thalidomide—leprosy	0.00193	0.0118	CcSEcCtD
Metoprolol—Amnesia—Thalidomide—leprosy	0.00191	0.0117	CcSEcCtD
Metoprolol—Vertigo—Dapsone—leprosy	0.00189	0.0116	CcSEcCtD
Metoprolol—Visual disturbance—Thalidomide—leprosy	0.00189	0.0116	CcSEcCtD
Metoprolol—Arthritis—Thalidomide—leprosy	0.00184	0.0113	CcSEcCtD
Metoprolol—Cardiac failure—Thalidomide—leprosy	0.00183	0.0113	CcSEcCtD
Metoprolol—Hypoglycaemia—Thalidomide—leprosy	0.00183	0.0113	CcSEcCtD
Metoprolol—Cerebrovascular accident—Thalidomide—leprosy	0.00183	0.0112	CcSEcCtD
Metoprolol—Disturbance in sexual arousal—Thalidomide—leprosy	0.00178	0.0109	CcSEcCtD
Metoprolol—Affect lability—Thalidomide—leprosy	0.00176	0.0108	CcSEcCtD
Metoprolol—Cardiac arrest—Thalidomide—leprosy	0.0017	0.0104	CcSEcCtD
Metoprolol—Mood swings—Thalidomide—leprosy	0.0017	0.0104	CcSEcCtD
Metoprolol—Tachycardia—Dapsone—leprosy	0.00168	0.0103	CcSEcCtD
Metoprolol—Liver function test abnormal—Thalidomide—leprosy	0.00165	0.0101	CcSEcCtD
Metoprolol—Orthostatic hypotension—Thalidomide—leprosy	0.00163	0.01	CcSEcCtD
Metoprolol—Breast disorder—Thalidomide—leprosy	0.00162	0.00992	CcSEcCtD
Metoprolol—Cramp muscle—Thalidomide—leprosy	0.00161	0.00989	CcSEcCtD
Metoprolol—Insomnia—Dapsone—leprosy	0.00155	0.00954	CcSEcCtD
Metoprolol—Bronchospasm—Thalidomide—leprosy	0.00152	0.00934	CcSEcCtD
Metoprolol—Angina pectoris—Thalidomide—leprosy	0.00151	0.00925	CcSEcCtD
Metoprolol—Erectile dysfunction—Thalidomide—leprosy	0.00142	0.00874	CcSEcCtD
Metoprolol—Photosensitivity reaction—Thalidomide—leprosy	0.00141	0.00866	CcSEcCtD
Metoprolol—Weight increased—Thalidomide—leprosy	0.00141	0.00864	CcSEcCtD
Metoprolol—Gastrointestinal pain—Dapsone—leprosy	0.00141	0.00862	CcSEcCtD
Metoprolol—Pneumonia—Thalidomide—leprosy	0.00139	0.00851	CcSEcCtD
Metoprolol—Depression—Thalidomide—leprosy	0.00138	0.00844	CcSEcCtD
Metoprolol—Abdominal pain—Dapsone—leprosy	0.00136	0.00834	CcSEcCtD
Metoprolol—Body temperature increased—Dapsone—leprosy	0.00136	0.00834	CcSEcCtD
Metoprolol—Conjunctivitis—Thalidomide—leprosy	0.00134	0.00823	CcSEcCtD
Metoprolol—Sweating—Thalidomide—leprosy	0.00132	0.00811	CcSEcCtD
Metoprolol—Agranulocytosis—Thalidomide—leprosy	0.00129	0.0079	CcSEcCtD
Metoprolol—Bradycardia—Thalidomide—leprosy	0.00126	0.00773	CcSEcCtD
Metoprolol—Rhinitis—Thalidomide—leprosy	0.00124	0.00762	CcSEcCtD
Metoprolol—Hepatitis—Thalidomide—leprosy	0.00124	0.0076	CcSEcCtD
Metoprolol—Oedema peripheral—Thalidomide—leprosy	0.00122	0.00748	CcSEcCtD
Metoprolol—Visual impairment—Thalidomide—leprosy	0.00119	0.00732	CcSEcCtD
Metoprolol—Eye disorder—Thalidomide—leprosy	0.00116	0.0071	CcSEcCtD
Metoprolol—Tinnitus—Thalidomide—leprosy	0.00115	0.00708	CcSEcCtD
Metoprolol—Cardiac disorder—Thalidomide—leprosy	0.00115	0.00705	CcSEcCtD
Metoprolol—Angiopathy—Thalidomide—leprosy	0.00112	0.00689	CcSEcCtD
Metoprolol—Immune system disorder—Thalidomide—leprosy	0.00112	0.00686	CcSEcCtD
Metoprolol—Mediastinal disorder—Thalidomide—leprosy	0.00112	0.00685	CcSEcCtD
Metoprolol—Arrhythmia—Thalidomide—leprosy	0.00111	0.00679	CcSEcCtD
Metoprolol—Alopecia—Thalidomide—leprosy	0.00109	0.00671	CcSEcCtD
Metoprolol—Vomiting—Dapsone—leprosy	0.00109	0.0067	CcSEcCtD
Metoprolol—Mental disorder—Thalidomide—leprosy	0.00108	0.00666	CcSEcCtD
Metoprolol—Headache—Dapsone—leprosy	0.00108	0.00661	CcSEcCtD
Metoprolol—Flatulence—Thalidomide—leprosy	0.00106	0.00652	CcSEcCtD
Metoprolol—Tension—Thalidomide—leprosy	0.00106	0.00649	CcSEcCtD
Metoprolol—Dysgeusia—Thalidomide—leprosy	0.00106	0.00648	CcSEcCtD
Metoprolol—Nervousness—Thalidomide—leprosy	0.00105	0.00642	CcSEcCtD
Metoprolol—Muscle spasms—Thalidomide—leprosy	0.00104	0.00636	CcSEcCtD
Metoprolol—Nausea—Dapsone—leprosy	0.00102	0.00626	CcSEcCtD
Metoprolol—Vision blurred—Thalidomide—leprosy	0.00102	0.00623	CcSEcCtD
Metoprolol—Vertigo—Thalidomide—leprosy	0.000969	0.00594	CcSEcCtD
Metoprolol—Syncope—Thalidomide—leprosy	0.000967	0.00593	CcSEcCtD
Metoprolol—Leukopenia—Thalidomide—leprosy	0.000965	0.00592	CcSEcCtD
Metoprolol—Palpitations—Thalidomide—leprosy	0.000953	0.00584	CcSEcCtD
Metoprolol—Loss of consciousness—Thalidomide—leprosy	0.000948	0.00581	CcSEcCtD
Metoprolol—Hypertension—Thalidomide—leprosy	0.000931	0.00571	CcSEcCtD
Metoprolol—Arthralgia—Thalidomide—leprosy	0.000918	0.00563	CcSEcCtD
Metoprolol—Chest pain—Thalidomide—leprosy	0.000918	0.00563	CcSEcCtD
Metoprolol—Anxiety—Thalidomide—leprosy	0.000915	0.00561	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000911	0.00559	CcSEcCtD
Metoprolol—Dry mouth—Thalidomide—leprosy	0.000898	0.00551	CcSEcCtD
Metoprolol—Confusional state—Thalidomide—leprosy	0.000887	0.00544	CcSEcCtD
Metoprolol—Oedema—Thalidomide—leprosy	0.00088	0.0054	CcSEcCtD
Metoprolol—Shock—Thalidomide—leprosy	0.000866	0.00531	CcSEcCtD
Metoprolol—Nervous system disorder—Thalidomide—leprosy	0.000863	0.00529	CcSEcCtD
Metoprolol—Thrombocytopenia—Thalidomide—leprosy	0.000861	0.00528	CcSEcCtD
Metoprolol—Tachycardia—Thalidomide—leprosy	0.000859	0.00527	CcSEcCtD
Metoprolol—Skin disorder—Thalidomide—leprosy	0.000855	0.00524	CcSEcCtD
Metoprolol—Hyperhidrosis—Thalidomide—leprosy	0.000851	0.00522	CcSEcCtD
Metoprolol—Hypotension—Thalidomide—leprosy	0.000822	0.00504	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Thalidomide—leprosy	0.000802	0.00492	CcSEcCtD
Metoprolol—Insomnia—Thalidomide—leprosy	0.000796	0.00488	CcSEcCtD
Metoprolol—Paraesthesia—Thalidomide—leprosy	0.00079	0.00485	CcSEcCtD
Metoprolol—Dyspnoea—Thalidomide—leprosy	0.000784	0.00481	CcSEcCtD
Metoprolol—Somnolence—Thalidomide—leprosy	0.000782	0.0048	CcSEcCtD
Metoprolol—Dyspepsia—Thalidomide—leprosy	0.000774	0.00475	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Thalidomide—leprosy	0.00076	0.00466	CcSEcCtD
Metoprolol—Fatigue—Thalidomide—leprosy	0.000759	0.00465	CcSEcCtD
Metoprolol—Constipation—Thalidomide—leprosy	0.000752	0.00462	CcSEcCtD
Metoprolol—Pain—Thalidomide—leprosy	0.000752	0.00462	CcSEcCtD
Metoprolol—Feeling abnormal—Thalidomide—leprosy	0.000725	0.00445	CcSEcCtD
Metoprolol—Gastrointestinal pain—Thalidomide—leprosy	0.000719	0.00441	CcSEcCtD
Metoprolol—Urticaria—Thalidomide—leprosy	0.000699	0.00429	CcSEcCtD
Metoprolol—Abdominal pain—Thalidomide—leprosy	0.000696	0.00427	CcSEcCtD
Metoprolol—Body temperature increased—Thalidomide—leprosy	0.000696	0.00427	CcSEcCtD
Metoprolol—Hypersensitivity—Thalidomide—leprosy	0.000648	0.00398	CcSEcCtD
Metoprolol—Asthenia—Thalidomide—leprosy	0.000631	0.00387	CcSEcCtD
Metoprolol—Pruritus—Thalidomide—leprosy	0.000622	0.00382	CcSEcCtD
Metoprolol—Diarrhoea—Thalidomide—leprosy	0.000602	0.00369	CcSEcCtD
Metoprolol—Dizziness—Thalidomide—leprosy	0.000582	0.00357	CcSEcCtD
Metoprolol—Vomiting—Thalidomide—leprosy	0.000559	0.00343	CcSEcCtD
Metoprolol—Rash—Thalidomide—leprosy	0.000555	0.0034	CcSEcCtD
Metoprolol—Dermatitis—Thalidomide—leprosy	0.000554	0.0034	CcSEcCtD
Metoprolol—Headache—Thalidomide—leprosy	0.000551	0.00338	CcSEcCtD
Metoprolol—Nausea—Thalidomide—leprosy	0.000523	0.00321	CcSEcCtD
